SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-18-044625
Filing Date
2018-08-14
Accepted
2018-08-14 16:03:33
Documents
39
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q tv499945_10q.htm 10-Q 259069
2 EXHIBIT 31 tv499945_ex31.htm EX-31 8597
3 EXHIBIT 32 tv499945_ex32.htm EX-32 4184
  Complete submission text file 0001144204-18-044625.txt   1987631

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT bpth-20180630.xml EX-101.INS 329444
5 XBRL TAXONOMY EXTENSION SCHEMA bpth-20180630.xsd EX-101.SCH 26092
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bpth-20180630_cal.xml EX-101.CAL 20228
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bpth-20180630_def.xml EX-101.DEF 156268
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE bpth-20180630_lab.xml EX-101.LAB 193086
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bpth-20180630_pre.xml EX-101.PRE 169254
Mailing Address 4710 BELLAIRE BOULEVARD SUITE 210 BELLAIRE TX 77401
Business Address 4710 BELLAIRE BOULEVARD SUITE 210 BELLAIRE TX 77401 (832) 742-1357
BIO-PATH HOLDINGS INC (Filer) CIK: 0001133818 (see all company filings)

IRS No.: 870652870 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36333 | Film No.: 181017263
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1